• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子受体1(VEGFR1)通过磷脂酶Cγ(PLCγ)和磷脂酰肌醇-3激酶(PI3K)信号通路促进细胞迁移和增殖。

VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways.

作者信息

Weddell Jared C, Chen Si, Imoukhuede P I

机构信息

Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801 USA.

出版信息

NPJ Syst Biol Appl. 2017 Dec 19;4:1. doi: 10.1038/s41540-017-0037-9. eCollection 2018.

DOI:10.1038/s41540-017-0037-9
PMID:29263797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5736688/
Abstract

The ability to control vascular endothelial growth factor (VEGF) signaling offers promising therapeutic potential for vascular diseases and cancer. Despite this promise, VEGF-targeted therapies are not clinically effective for many pathologies, such as breast cancer. VEGFR1 has recently emerged as a predictive biomarker for anti-VEGF efficacy, implying a functional VEGFR1 role beyond its classically defined decoy receptor status. Here we introduce a computational approach that accurately predicts cellular responses elicited via VEGFR1 signaling. Aligned with our model prediction, we show empirically that VEGFR1 promotes macrophage migration through PLC and PI3K pathways and promotes macrophage proliferation through a PLC pathway. These results provide new insight into the basic function of VEGFR1 signaling while offering a computational platform to quantify signaling of any receptor.

摘要

控制血管内皮生长因子(VEGF)信号传导的能力为血管疾病和癌症提供了有前景的治疗潜力。尽管有此前景,但VEGF靶向疗法对许多病症(如乳腺癌)在临床上并不有效。VEGFR1最近已成为抗VEGF疗效的预测生物标志物,这意味着VEGFR1的功能超出了其经典定义的诱饵受体状态。在此,我们介绍一种计算方法,该方法可准确预测通过VEGFR1信号传导引发的细胞反应。与我们的模型预测一致,我们通过实验表明,VEGFR1通过PLC和PI3K途径促进巨噬细胞迁移,并通过PLC途径促进巨噬细胞增殖。这些结果为VEGFR1信号传导的基本功能提供了新的见解,同时提供了一个计算平台来量化任何受体的信号传导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/f9d3969da883/41540_2017_37_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/2882ca22510a/41540_2017_37_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/d2fff995bba6/41540_2017_37_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/9d7113a12b5b/41540_2017_37_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/4f1d56fa5c50/41540_2017_37_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/92f2e9eb32ee/41540_2017_37_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/f9d3969da883/41540_2017_37_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/2882ca22510a/41540_2017_37_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/d2fff995bba6/41540_2017_37_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/9d7113a12b5b/41540_2017_37_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/4f1d56fa5c50/41540_2017_37_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/92f2e9eb32ee/41540_2017_37_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c9/5736688/f9d3969da883/41540_2017_37_Fig6_HTML.jpg

相似文献

1
VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways.血管内皮生长因子受体1(VEGFR1)通过磷脂酶Cγ(PLCγ)和磷脂酰肌醇-3激酶(PI3K)信号通路促进细胞迁移和增殖。
NPJ Syst Biol Appl. 2017 Dec 19;4:1. doi: 10.1038/s41540-017-0037-9. eCollection 2018.
2
VEGF-A promotes the motility of human melanoma cells through the VEGFR1-PI3K/Akt signaling pathway.VEGF-A 通过 VEGFR1-PI3K/Akt 信号通路促进人黑色素瘤细胞的迁移。
In Vitro Cell Dev Biol Anim. 2022 Sep;58(8):758-770. doi: 10.1007/s11626-022-00717-3. Epub 2022 Aug 23.
3
VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway.VEGFB 通过 VEGFR1-PI3K/Akt 信号通路促进成肌细胞的增殖和分化。
Int J Mol Sci. 2021 Dec 12;22(24):13352. doi: 10.3390/ijms222413352.
4
VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.血管内皮生长因子A165通过激活神经纤毛蛋白-1-血管内皮生长因子受体1-磷脂酰肌醇-3-激酶轴诱导人主动脉平滑肌细胞迁移。
Biochemistry. 2008 Mar 18;47(11):3345-51. doi: 10.1021/bi8000352. Epub 2008 Feb 20.
5
Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.抗Flt1肽是一种血管内皮生长因子受体1特异性六肽,可抑制肿瘤生长和转移。
Clin Cancer Res. 2005 Apr 1;11(7):2651-61. doi: 10.1158/1078-0432.CCR-04-1564.
6
Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.自分泌血管内皮生长因子受体1(VEGFR1)和血管内皮生长因子受体2(VEGFR2)信号传导在体外和体内的人胶质母细胞瘤模型中促进细胞存活。
Neuro Oncol. 2016 Sep;18(9):1242-52. doi: 10.1093/neuonc/now043. Epub 2016 Mar 23.
7
Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.新型肽双重阻断 VEGFR1 和 VEGFR2 可通过 PI3K/AKT 和 MAPK/ERK1/2 通路阻断 VEGF 驱动的血管生成、肿瘤生长和转移。
Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2688-2700. doi: 10.1016/j.bbagen.2018.08.013. Epub 2018 Aug 21.
8
VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases.作为抑制炎症及其他疾病靶点的血管内皮生长因子-血管内皮生长因子受体系统
Endocr Metab Immune Disord Drug Targets. 2015;15(2):135-44. doi: 10.2174/1871530315666150316121956.
9
Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.针对 VEGFR1 和 VEGFR2 信号通路作为治疗乳腺癌的潜在靶点。
Mol Biol Rep. 2020 Mar;47(3):2061-2071. doi: 10.1007/s11033-020-05306-9. Epub 2020 Feb 18.
10
ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin.ACSL4 促进结直肠癌的发生,是大黄素的潜在治疗靶点。
Phytomedicine. 2022 Jul 20;102:154149. doi: 10.1016/j.phymed.2022.154149. Epub 2022 May 6.

引用本文的文献

1
VEGFR1 as a Target for Cardiovascular Gene Therapy.血管内皮生长因子受体1作为心血管基因治疗的靶点
J Cardiovasc Transl Res. 2025 Aug 21. doi: 10.1007/s12265-025-10672-5.
2
CTCF Represses CIB2 to Balance Proliferation and Differentiation of Goat Myogenic Satellite Cells via Integrin α7β1-PI3K/AKT Axis.CTCF通过整合素α7β1-PI3K/AKT轴抑制CIB2以平衡山羊成肌卫星细胞的增殖和分化。
Cells. 2025 Aug 5;14(15):1199. doi: 10.3390/cells14151199.
3
Adipocytokine Protein Expression from Visceral Fat Differs Significantly Based on Diet, Sex, and Age in C3H/HeJ Mice Fed Long-Term, High-Fat Diets, ± Ammonium-Hydroxide-Supplemented Dietary Protein.

本文引用的文献

1
VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis.与血管生成相关的内皮细胞中的VEGF-A/VEGFR2信号网络。
J Cell Commun Signal. 2016 Dec;10(4):347-354. doi: 10.1007/s12079-016-0352-8. Epub 2016 Sep 12.
2
Modeling cell adhesion and proliferation: a cellular-automata based approach.细胞黏附与增殖建模:一种基于细胞自动机的方法。
Adv Model Simul Eng Sci. 2015;2:32. doi: 10.1186/s40323-015-0053-5. Epub 2015 Dec 2.
3
Multi-class and multi-scale models of complex biological phenomena.复杂生物现象的多类别和多尺度模型。
长期喂食高脂饮食(±添加氢氧化铵的膳食蛋白质)的C3H/HeJ小鼠,内脏脂肪中的脂肪细胞因子蛋白表达因饮食、性别和年龄而存在显著差异。
Curr Issues Mol Biol. 2025 Mar 23;47(4):218. doi: 10.3390/cimb47040218.
4
Logic-based modeling of inflammatory macrophage cross talk with glomerular endothelial cells in diabetic kidney disease.糖尿病肾病中炎症性巨噬细胞与肾小球内皮细胞相互作用的基于逻辑的建模
Am J Physiol Renal Physiol. 2025 Jul 1;329(1):F202-F224. doi: 10.1152/ajprenal.00362.2024. Epub 2025 May 26.
5
Progress of microneedle targeted modulation technology in the reconstruction of immune microenvironment in diabetic wounds.微针靶向调控技术在糖尿病创面免疫微环境重建中的研究进展
Eur J Med Res. 2025 May 20;30(1):405. doi: 10.1186/s40001-025-02667-4.
6
Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance.靶向血管内皮生长因子受体-2(VEGFR-2):结构生物学、功能见解及治疗抗性
Arch Pharm Res. 2025 May 8. doi: 10.1007/s12272-025-01545-1.
7
Vascular Endothelial Growth Factor Receptors in the Vascularization of Pancreatic Tumors: Implications for Prognosis and Therapy.血管内皮生长因子受体在胰腺肿瘤血管生成中的作用:对预后和治疗的影响
Curr Issues Mol Biol. 2025 Mar 10;47(3):179. doi: 10.3390/cimb47030179.
8
VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway.VEGFB 通过 PI3K/AKT 信号通路改善非酒精性脂肪性肝病的胰岛素抵抗。
J Transl Med. 2024 Oct 28;22(1):976. doi: 10.1186/s12967-024-05621-w.
9
Characterizing a stable five-species microbial community for use in experimental evolution and ecology.用于实验进化和生态学的稳定五物种微生物群落的特征。
Microbiology (Reading). 2024 Sep;170(9). doi: 10.1099/mic.0.001489.
10
Molecular basis of VEGFR1 autoinhibition at the plasma membrane.血管内皮生长因子受体 1 在质膜处的自身抑制的分子基础。
Nat Commun. 2024 Feb 14;15(1):1346. doi: 10.1038/s41467-024-45499-2.
Curr Opin Biotechnol. 2016 Jun;39:167-173. doi: 10.1016/j.copbio.2016.04.002. Epub 2016 Apr 23.
4
Endothelial cells decode VEGF-mediated Ca2+ signaling patterns to produce distinct functional responses.内皮细胞解码VEGF介导的Ca2+信号模式以产生不同的功能反应。
Sci Signal. 2016 Feb 23;9(416):ra20. doi: 10.1126/scisignal.aad3188.
5
Pharmacokinetics of Anti-VEGF Agent Aflibercept in Cancer Predicted by Data-Driven, Molecular-Detailed Model.由数据驱动的分子详细模型预测的抗血管内皮生长因子药物阿柏西普在癌症中的药代动力学
CPT Pharmacometrics Syst Pharmacol. 2015 Nov;4(11):641-9. doi: 10.1002/psp4.12040. Epub 2015 Oct 9.
6
Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk.单核细胞衍生的巨噬细胞辅助乳腺癌细胞侵袭,作为一种个性化的预测指标来评估转移风险。
Sci Rep. 2015 Sep 9;5:13855. doi: 10.1038/srep13855.
7
How computational models can help unlock biological systems.计算模型如何助力解开生物系统之谜。
Semin Cell Dev Biol. 2015 Dec;47-48:62-73. doi: 10.1016/j.semcdb.2015.07.001. Epub 2015 Jul 9.
8
The phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: Alliance or contradiction? (Review).癌症中的磷脂酰肌醇3-激酶/蛋白激酶B和c-Jun氨基末端激酶信号传导:联盟还是矛盾?(综述)
Int J Oncol. 2015 Aug;47(2):429-36. doi: 10.3892/ijo.2015.3052. Epub 2015 Jun 16.
9
Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model.血管内皮生长因子受体2(VEGFR2)的位点特异性磷酸化由受体转运介导:来自计算模型的见解
PLoS Comput Biol. 2015 Jun 12;11(6):e1004158. doi: 10.1371/journal.pcbi.1004158. eCollection 2015 Jun.
10
Ca2+ signaling in cytoskeletal reorganization, cell migration, and cancer metastasis.钙离子信号传导在细胞骨架重组、细胞迁移和癌症转移中的作用。
Biomed Res Int. 2015;2015:409245. doi: 10.1155/2015/409245. Epub 2015 Apr 22.